We further demonstrated that inhibition of FGF19 not only suppresses HCC metastasis but also increases its sensitivity to sorafenib by enhancing reactive oxygen species (ROS)-associated apoptosis [8]. Here, FGF19 is linked to hepatocellular carcinoma.